Billing and Coding: MolDX: Biomarkers in Cardiovascular Risk Assessment

This article (A57055) provides billing and coding guidance that complements the MolDX LCD L36362 for biomarkers in cardiovascular risk assessment and does not itself define clinical coverage criteria. For coverage, limitations, documentation, and any frequency limits, refer to LCD L36362 and MolDX program instructions; this article should be used only to clarify billing/coding practices.

"No clinical indications are specified in this article; coverage indications are determined by the referenced LCD L36362 (MolDX: Biomarkers in Cardiovascular Risk Assessment)."

Sign up to see full coverage criteria, indications, and limitations.